FilingReader Intelligence
MedPlus subsidiary faces drug license suspension
July 26, 2025 at 03:09 PM UTC•By FilingReader AI
MedPlus Health Services announced that its subsidiary, Optival Health Solutions Private Limited, received a three-day suspension of a drug license for a store in Vishakapatnam, Andhra Pradesh.
The suspension falls under Rule 65 of the Drugs and Cosmetics Act, 1940. The potential revenue loss is estimated at Rs 0.69 lacs.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:MEDPLUS•Bombay Stock Exchange
News Alerts
Get instant email alerts when Medplus Health Services publishes news
Free account required • Unsubscribe anytime